FDA nod for Aurobindo’s Sildenafil injection

The US health regulator has approved Aurobindo Pharma’s Sildenafil injection, used for treating pulmonary arterial hypertension


Sildenafil is a generic version of Pfizer's Revatio injection

Aurobindo Pharma has announced that it has received approval from the US Food and Drug Administration ( US FDA) to manufacture and market Sildenafil injection.

Sildenafil injection is a generic version of Pfizer's Revatio injection.

The injection is indicated for the treatment of adult patients with pulmonary arterial hypertension who are temporarily unable to take oral therapy, but are otherwise clinically and haemodynamically stable.



Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email